Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06489912
Recruiting Observational

Overview of the Mental Health of Adolescents in Therapeutci, Educational and Pedagogical Facilities in France

NCT06489912 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Rouen
Phase
Observational
Started
2024-12-20
Last updated
2026-06-10

Condition(s) studied

Mental Health Disorder

Investigational drug(s) / intervention(s)

WAIS IV

WAIS IV: Psychological assessement

Study summary

Assess the prevalence of various psychiatric disorders in adolescents aged 12 to 16 receiving support from therapeutic, educational and pedagogical institutes.

Eligibility

Sex
ALL
Min age
12 Years
Max age
16 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Adolescent aged 12 to 16 * In a DITEP for at least 15 days * Minor who has been informed and has not objected to the research (according to his/her capacity) * At least one person exercising parental authority who has read and understood the information note and has not objected to the research OR * For a minor under guardianship: legal representative who has read and understood the information note and has not objected to the research. Exclusion Criteria: * Minor and/or person(s) exercising parental authority who do not understand French * Holder of parental authority opposed to the search * Minor opposed to search

Primary outcome measure(s)

  • Presence of psychiatric disorders — Inclusion
    assessed according to DSM-5 by K- SADS-PL
  • nature of psychiatric disorders — Inclusion
    assessed according to DSM-5 by K- SADS-PL

Trial sites (2)

FacilityCityRegionStatus
CHU Bourgogne Franche Comté Besançon France Recruiting
Chu Rouen Rouen France Recruiting

More University Hospital, Rouen trials in France

Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain. Recruiting
Cohort for Monitoring Patients With Venous Thromboembolic Disease Recruiting
Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus Recruiting
Use of Omics Methods to Classify Variations of Uncertain Significance and Improve Diagnosis of Neurogenetic Diseases Recruiting
Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients Recruiting

Other trials for the same condition

Police Officers' Mental Health and Occupational Health Monitoring Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06489912 on ClinicalTrials.gov ↗ ← All trials in France